Initial clinical tests show that biosensors could pave the way for a personalized antibiotherapy in the future
Personalized drug therapy, adjusting the dose, dosage intervals, and the duration of treatment to fit individual patients’ needs, are getting more and more important. Frequently, medications are dosed in such a way that each patient receives the same standardized amount of a certain drug. Thereby, clinical conditions of the patient, such as state of health, metabolism, or other physical factors, are often not sufficiently considered. A researcher team at the University of Freiburg has developed a bioanalytical method which can measure the class of ?-lactam antibiotics in human blood on-site – in the operating room, intensive ward or doctor’s office, as well as on a house call. “This way, we can easily determine just how quickly the human body metabolizes a drug,” said the microsystems engineer Dr. Can Dincer, who is the head of the research team. The researchers recently published their results in the journal “Scientific Reports”.
This new method makes it possible to individually adjust the necessary dose of a medication for each patient. “We’ve proven the applicability of our system for a personalized antibiotherapy by on-site monitoring the clearance of drugs in two patients, who were treated with ß-lactam antibiotics, undergoing surgery” Dincer said. “Based on these results, our next step will be to perform a quantitative cohort study that will determine the usefulness of personalized antibiotherapy.”, he added.
Already at the end of 2016, the research team presented its biosensor technology that allows the rapid and simultaneous monitoring of different antibiotics in human blood (www.pr.uni-freiburg.de/pm/2016/pm.2016-11-14.159). In their recently published study, the scientists further developed their system by implementing another natural sensor protein that can quantify ?-lactam antibiotics. In human medicine, ?-lactam antibiotics are often used to prevent and treat infectious diseases.
Learn more: Personalize your medication dosages
The Latest on: Personalized medicine
[google_news title=”” keyword=”personalized medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Dr. Shanda Blackmon named director of The Lung Institute at Baylor Medicineon April 25, 2024 at 5:01 am
Dr. Shanda H. Blackmon, renowned in the field of thoracic surgery, specializing in minimally invasive lung segmentectomy and complex thoracic ...
- Moderna and OpenAI Collaborate To Advance mRNA Medicineon April 24, 2024 at 4:11 am
Generative AI will help advance Moderna’s broad and diverse portfolio to maximize the Company’s impact on patients ...
- AI could predict whether cancer treatments will work, experts say: ‘Exciting time in medicine'on April 23, 2024 at 3:00 am
A chemotherapy alternative called immunotherapy is showing promise in treating cancer — and a new artificial intelligence tool could help ensure that patients have the best possible experience.
- 8 Clinical Trials That Will Shape Medicine in 2024on April 22, 2024 at 10:13 am
One of the exciting things about modern medicine is that it is making increasingly rapid advancements in a number of key areas. These advancements could have a major impact on the future of medicine.
- Progesterone Therapy in Demand for Personalized Medicine: Market to Reach US$4.8 Billion by 2034 | Future Market Insights, Inc.on April 22, 2024 at 3:30 am
After extensive research, the progesterone market suggests an upward trajectory from 2024 to 2034, inferring a healthy CAGR of 12.30%. With preliminary valuations of US$ 1.50 billion in 2024, the ...
- How AI can help cancer patients receive personalized and precise treatment fasteron April 16, 2024 at 1:35 pm
Providence and Microsoft are developing research prototype AI tools to sort through growing mountains of patient data.
- Q&A: When will patients see personalized cancer vaccines?on April 16, 2024 at 10:43 am
Catherine Wu has been a pioneer in a promising approach to fight cancer: vaccines that target specific immune-stimulating molecules, known as immunogenic peptides, generated by the distinct genetic ...
- The Future of Breast Cancer Care: Blackwood on Personalized Approacheson April 15, 2024 at 8:01 am
In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing is changing the field.
- Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and moreon April 12, 2024 at 5:00 pm
This essay supports my assertion that the fiscal issues that might hinder the usefulness of personalized medicine need to be dealt with at the same time as we continue our progress towards large ...
- Predictive & Personalized Medicine Market to Grow at CAGR of 8.2% by 2032on April 12, 2024 at 5:49 am
According to a recent report by Market.us, the Global Predictive & Personalized Medicine Market size is expected to be worth around USD 692.0 Billion by 2032 from USD 347.2 Billion in 2023, growing at ...
via Google News and Bing medicine